InforSense Ltd., the leading provider of next-generation business and scientific intelligence tools, today announced that Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has begun shipping its Proteome Discoverer software with integrated protein annotation powered by the InforSense Virtual Machine (IVM). This is the first Thermo Fisher Scientific software that embeds the IVM and marks a major milestone in a long relationship between the two companies.
Proteome Discoverer's protein annotation capabilities are based on workflows jointly developed by Thermo Fisher Scientific and InforSense. The workflows perform automated annotation of proteomics data using information from NCBI and SWISS-PROT to provide biological context to experimental data. The workflows in Proteome Discoverer are powered by the IVM: a lightweight, analytical workflow execution engine that can run on a wide variety of platforms including workstations, servers, scientific instrumentation, and mobile devices. As a result of its small footprint, it is effortlessly installed and simple to maintain, update and extend, eliminating the complexity typically found with traditional software installations.
Proteome Discoverer is fully compatible with the InforSense 5.0 platform, and customers will be able to build their own annotation workflows and share them via the InforSense CustomerHub on-line community. Users of Proteome Discoverer can upgrade to a full InforSense license to build their own analytical workflows and integrate internal data to provide further annotation.
"As proteomics has evolved, the need to support advanced and flexible annotation of proteomics data has grown. The IVM gives us the power and flexibility to support the changing requirements of our customers," said Andreas Hühmer, Proteomics Marketing Director, Thermo Fisher Scientific.
"The ability to update client software without performing a new distribution and installation is a major advantage to us, reducing our costs and improving our ability to respond to our customers."
"Today's announcement is an important milestone for Thermo Fisher and InforSense, and we are delighted to have worked closely with them to introduce the first Virtual Machine-based product to the market," said Prof.
Yike Guo, Founder and Chief Executive Officer of InforSense Ltd. "Our work with Thermo Fisher Scientific is a key collaboration for us and illustrates how our next generation scientific business intelligence technology is effectively automating data integration and analysis tasks. We believe that this real time analytics model is an important step forward for the life sciences industry."
About Proteome Discoverer
Proteome Discoverer is a new proteomics analysis software platform that gives scientists the most comprehensive view of quantitative and qualitative proteomic data available today. It enables researchers to combine and compare data from multiple search engines, public databases, and dissociation methods on a larger scale than ever possible, in a program that is easy-to-use and flexible.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer.
With annual revenues of $10 billion, the company has more than 30,000 employees and serves over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, the company helps solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions.
Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, the company offers the most convenient purchasing options to customers and continuously advances its technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike.
InforSense (inforsense.com) goes beyond traditional business intelligence to provide a completely integrated suite of agile, visual and predictive intelligence solutions, enabling organizations to gain business and scientific insights and optimize their business-critical decision-making processes. Leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies around the world rely on InforSense to quickly, easily deliver intelligence and identify trends in data. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.
InforSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.